Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Cogent Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 137
- +2 vs. Q4 2022
- Shares held
- 75.3M
- +402.6K (+0.5%) vs. Q4 2022
- Total value
- $810.4M
- −$53.7M (−6.2%) vs. Q4 2022
- New holders
- 15
- 43 more added
- Sold out
- 13
- 46 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COGT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 322 | $7.50B |
| Q1 2026 | 305 | $7.17B |
| Q4 2025 | 267 | $6.18B |
| Q3 2025 | 195 | $2.29B |
| Q2 2025 | 181 | $973.2M |
| Q1 2025 | 186 | $799.6M |
| Q4 2024 | 177 | $949.5M |
| Q3 2024 | 161 | $1.32B |
| Q2 2024 | 149 | $1.02B |
| Q1 2024 | 146 | $734.3M |
| Q4 2023 | 144 | $534.0M |
| Q3 2023 | 135 | $885.8M |
| Q2 2023 | 136 | $1.05B |
| Q1 2023 | 137 | $810.4M |
| Q4 2022 | 135 | $864.1M |
| Q3 2022 | 134 | $1.10B |
| Q2 2022 | 112 | $633.3M |
| Q1 2022 | 86 | $353.6M |
| Q4 2021 | 82 | $385.2M |
| Q3 2021 | 73 | $309.6M |
| Q2 2021 | 69 | $293.7M |
| Q1 2021 | 69 | $303.3M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Cogent Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 461,834 | $4.98M | 0.01% | −271,626−37.0% | Reduced |
| Platinum Investment Management Ltd | 477,080 | $5.15M | 0.18% | −34,310−6.7% | Reduced |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5.41M | 4.47% | 00.0% | Unchanged |
| Boxer Capital, LLC | 525,000 | $5.67M | 0.28% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 550,000 | $5.93M | 2.25% | −250,000−31.3% | Reduced |
| Northern Trust Corp | 550,928 | $5.94M | 0.00% | +8,193+1.5% | Added |
| Goldman Sachs Group Inc | 553,730 | $5.97M | 0.00% | −92,007−14.2% | Reduced |
| Silverarc Capital Management, LLC | 579,264 | $6.25M | 2.81% | +400,264+223.6% | Added |
| Assenagon Asset Management S.A. | 698,271 | $7.53M | 0.03% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 700,000 | $7.55M | 0.50% | −200,000−22.2% | Reduced |
| Walleye Capital LLC | 786,596 | $8.49M | 0.17% | +342,493+77.1% | Added |
| 5AM Venture Management, LLC | 790,440 | $8.53M | 2.18% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 828,962 | $8.94M | 0.00% | +362,943+77.9% | Added |
| Candriam Luxembourg S.C.A. | 937,141 | $9.31M | 0.06% | −60,000−6.0% | Reduced |
| Farallon Capital Management, L.L.C. | 983,452 | $10.6M | 0.06% | +898,313+1,055.1% | Added |
| Logos Global Management LP | 1,000,000 | $10.8M | 1.54% | −100,000−9.1% | Reduced |
| Citadel Advisors LLC | 1,295,772 | $14.0M | 0.02% | −558,548−30.1% | Reduced |
| Geode Capital Management, LLC | 1,318,308 | $14.2M | 0.00% | +95,978+7.9% | Added |
| Adage Capital Partners GP, L.L.C. | 1,386,613 | $15.0M | 0.03% | +350,000+33.8% | Added |
| Janus Henderson Group PLC | 1,662,265 | $17.9M | 0.01% | +60,068+3.7% | Added |
| Marshall Wace, LLP | 1,809,379 | $19.5M | 0.05% | +328,721+22.2% | Added |
| Suvretta Capital Management, LLC | 1,819,693 | $19.6M | 0.95% | +8,297+0.5% | Added |
| Vivo Capital, LLC | 1,994,941 | $21.5M | 1.61% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 2,159,154 | $23.3M | 1.69% | +50,000+2.4% | Added |
| Point72 Asset Management, L.P. | 2,236,700 | $24.1M | 0.09% | +2,236,700 | New |
| Perceptive Advisors LLC | 2,282,324 | $24.6M | 0.73% | −925,117−28.8% | Reduced |
| Eventide Asset Management, LLC | 2,589,778 | $27.9M | 0.51% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 2,758,975 | $29.8M | 5.12% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,966,345 | $32.0M | 0.71% | 00.0% | Unchanged |
| State Street Corp | 3,427,714 | $37.0M | 0.00% | −833,667−19.6% | Reduced |
| Vanguard Group Inc | 3,536,259 | $38.2M | 0.00% | +70,467+2.0% | Added |
| TCG Crossover Management, LLC | 3,631,042 | $39.2M | 7.64% | 00.0% | Unchanged |
| Commodore Capital LP | 4,772,421 | $51.5M | 7.84% | +452,481+10.5% | Added |
| VR Adviser, LLC | 4,884,977 | $52.7M | 10.29% | +846,860+21.0% | Added |
| BlackRock Inc. | 5,042,070 | $54.4M | 0.00% | +95,627+1.9% | Added |
| Ra Capital Management, L.P. | 5,999,481 | $64.7M | 1.47% | 00.0% | Unchanged |
| Mirabella Financial Services LLP | 91,617 | – | – | −29,150−24.1% | Reduced |
| BVF Inc | 0 | $0 | 0.00% | −984,824−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −403,625−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −61,506−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −51,138−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −39,673−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −14,774−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −6,748−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −4,305−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,100−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −117−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |